Episodes: 200
Frequency: Irregular
Rating: 4.5/5.0
Estimated listeners: 1k-10k
Gender skew: Male
Location: USA
YouTube: 274.0k subscribers
Instagram: 118.0k followers
30s Ad: 90 - 111, 60s Ad: 107 - 128
Vineeta Agarwala - a16z Bio + Health veteran company builder/investor focused on biotechnology and healthcare innovation.
Julie Yoo - General Partner at a16z, working across health and technology investing with emphasis on how AI and new science reshape healthcare business models.
Jorge Conde - a16z Bio + Health operator/investor focused on building and scaling companies at the intersection of biotech, health, and frontier technology.
Unity Stoakes - AI Opportunity In Healthcare; Startup/company Stage Requirements For Seed/series A; Shifting Business Profile Of Health Tech
Dr. Daisy Wolf - AI And Peptides/sleep Tech Episode Framing And Science Discussion
Dr. Andrew Huberman - Ai-era Healthcare, Peptides/glp Landscape, Sleep/focus And Related Consumer Health Science; Implications For Future Neurotechnologies
Daisy Wolf & Eva Steinman (joint interviewers) - Behavioral Health Operating System Built With Ai; Ai-native Vs Ai-integrated; Platform Consolidation
Raymond Wang - AI Operating System For Behavioral Health; Product Integration Of Crm/ehr/rcm; Differentiation And Implementation Approach
Healthcare Will Benefit Most from AI | Julie Yoo on StartUp Health
April 21, 2026
This episode originally aired on StartUp Health. Unity Stoakes speaks with Julie Yoo, general partner at a16z, about why healthcare is poised to benefit more from AI than any other industry, how the business profile of health tech companies has fundamentally shifted, and what founders need to show up with today to stand out at the seed and Series A stages. Resources: Follow Julie Yoo on X: https://x.com/julesyoo Follow Unity on X: https://x.com/unitystoakes Hosted by Simplecast, an AdsWizz ...
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
March 09, 2026
Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the neurotechnologies Huberman believes will let us write to our own biology within the next five years. Resources: Follow Andrew Huberman on X: https://twitter.com/hubermanlab Follow ...
Rebuilding Behavioral Health’s Operating System with AI
March 02, 2026
a16z Partners Daisy Wolf and Eva Steinman talk with Zach Cohen and Raymond Wang, cofounders of Ease Health, a company building an AI operating system for behavioral health that combines CRM, EHR, and revenue cycle management into a single platform. They discuss why behavioral health software has lagged behind, what it means to build AI native versus AI integrated, and why Zach left his job as an investor at a16z to go build in this space. They also cover how Ease plans to replace the dozen so...
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings